Back to results
US 2021/0108181 A1Published application
Rift valley fever vaccine
AssigneeBoard of Regents, The University of Texas System
InventorTetsuro IKEGAMI
Life of this patent
Estimating the term…
Abstract
Certain embodiments are directed to an improved RVF vaccine for human use, and method for producing the same.
Claims18
A composition comprising a Rift Valley Fever Virus (RVFV) comprising:
- (i) an L segment having at least 90% identity to the nucleic acid sequence of SEQ ID NO:1,
- (ii) an M segment having at least 90% identity to the nucleic acid sequence of SEQ ID NO:4, and
- (iii) an S segment having at least 90% identity to the nucleic acid sequence of SEQ ID NO:3.
Dependencies are inferred from the claim text.